Semaglutide has emerged as a novel treatment for insulin resistance. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist acts upon stimulating the pancreas to release more insulin and suppressing glucagon https://idauhyo149345.estate-blog.com/34773280/comprehending-semaglutide-a-comprehensive-guide